Jump Financial’s Fulcrum Therapeutics FULC Stock Holding History

Jump Financial’s Portfolio FULC Stock Details FULC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.68M	Buy	1,005,000 +635,195	+172%	+$3.86M	0.03%	631
2026 Q1	$2.84M	Buy	369,805 +277,605	+301%	+$2.58M	0.04%	530
2025 Q4	$1.04M	Buy	+92,200	New	+$938K	0.01%	956
2025 Q2	–	Sell	-10,550	Closed	-$30.4K	–	1928
2025 Q1	$30.4K	Buy	+10,550	New	+$38.8K	﹤0.01%	1533
2024 Q3	–	Sell	-94,181	Closed	-$584K	–	1807
2024 Q2	$584K	Buy	94,181 +63,337	+205%	+$480K	0.01%	1074
2024 Q1	$291K	Buy	+30,844	New	+$275K	0.01%	1465
2023 Q4	–	Sell	-91,790	Closed	-$408K	–	1937
2023 Q3	$408K	Buy	+91,790	New	+$401K	0.02%	1125
2022 Q3	–	Sell	-29,000	Closed	-$142K	–	1710
2022 Q2	$142K	Buy	+29,000	New	+$283K	0.01%	1380
2022 Q1	–	Sell	-10,882	Closed	-$193K	–	1666
2021 Q4	$193K	Buy	+10,882	New	+$216K	0.01%	1124
2021 Q3	–	Sell	-12,699	Closed	-$133K	–	1219
2021 Q2	$133K	Buy	+12,699	New	+$128K	0.01%	949

Other funds holding FULC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jump Financial's FULC Position: Q2 2026 in Review

Jump Financial increased its Fulcrum Therapeutics (FULC) stake by 172% in Q2 2026, buying an estimated $3.86M and bringing the position to 1,005,000 shares worth $3.68M. The position accounts for 0.03% of the portfolio, ranked #631.

Jump Financial first reported a position in FULC in Q2 2021 and has held it in 10 quarters since. 154 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

Jump Financial held 1,005,000 shares of Fulcrum Therapeutics worth $3.68M as of Q2 2026.
Jump Financial bought 635,195 Fulcrum Therapeutics shares in Q2 2026, an estimated $3.86M.
Fulcrum Therapeutics made up 0.03% of Jump Financial's portfolio in Q2 2026, its #631 holding.
Jump Financial first reported a position in Fulcrum Therapeutics in Q2 2021 and has held it in 10 quarters since.
154 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.